Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult Participants

Administered by IM injection into the vastus lateralis

Administered by IM injection into the vastus lateralis

Administered as a IM or SC injection into the vastus lateralis or overlying subcutaneous tissue as the MVA dose

Administered as a IM or SC injection into the vastus lateralis or overlying subcutaneous tissue as the MVA dose

"Sodium Chloride for Injection, 0.9% USP~Administered as a IM or SC injection into the vastus lateralis or overlying subcutaneous tissue as the MVA dose"